Skip to content
Catalyst

methylphenidatePapers

Papers about methylphenidate

papers
1,014
42 years, by papers

Newest first

501 to 550 of 1,014

Every paper here, unless its row says otherwiseIndexed under methylphenidate in PubMed's chemical list; returned by a PubMed search for methylphenidate

  • Methylphenidate significantly reduces lapses of attention during on-road highway driving in patients with ADHD.

    Journal of clinical psychopharmacology2014PMID 24978156

  • Open-label dose optimization of methylphenidate modified release long acting (MPH-LA): a post hoc analysis of real-life titration from a 40-week randomized trial.

    Clinical drug investigation2014PMID 25015027

  • Comparative short term efficacy and tolerability of methylphenidate and atomoxetine in attention deficit hyperactivity disorder.

    Indian pediatrics2014PMID 25031133

  • Differential effects of MDMA and methylphenidate on social cognition.

    Journal of psychopharmacology (Oxford, England)2014PMID 25052243

  • Long-term (1 year) safety and efficacy of methylphenidate modified-release long-acting formulation (MPH-LA) in adults with attention-deficit hyperactivity disorder: a 26-week, flexible-dose, open-label extension to a 40-week, double-blind, randomised, placebo-controlled core study.

    CNS drugs2014PMID 25183661

  • The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.

    Orphanet journal of rare diseases2014PMID 25205361

  • Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.

    The Cochrane database of systematic reviews2014PMID 25230710

  • Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.

    Clinical drug investigation2014PMID 25274428

  • Effect of methylphenidate on height and weight in Korean children and adolescents with attention-deficit/hyperactivity disorder: a retrospective chart review.

    Journal of child and adolescent psychopharmacology2014PMID 25285915

  • A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.

    Journal of child and adolescent psychopharmacology2014PMID 25470572

  • Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.

    Journal of child and adolescent psychopharmacology2014PMID 25514542

  • Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate.

    The world journal of biological psychiatry2013PMID 21517701

  • Efficacy and safety of prolonged-release OROS methylphenidate in adults with attention deficit/hyperactivity disorder: a 13-week, randomized, double-blind, placebo-controlled, fixed-dose study.

    The world journal of biological psychiatry2013PMID 22106853

  • Methylphenidate effects on neural activity during response inhibition in healthy humans.

    Cerebral cortex (New York, N.Y.2013PMID 22581848

  • Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.

    Journal of child psychology and psychiatry, and allied disciplines2013PMID 22676856

  • Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.

    European neuropsychopharmacology2013PMID 22709890

  • Long-term relationship between methylphenidate and tobacco consumption and nicotine craving in adults with ADHD in a prospective cohort study.

    European neuropsychopharmacology2013PMID 22809706

  • Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate.

    The Journal of pediatrics2013PMID 22878114

  • Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: a review of controlled and naturalistic studies.

    European neuropsychopharmacology2013PMID 22917983

  • Osmotic release oral system methylphenidate prevents weight gain during a smoking-cessation attempt in adults with ADHD.

    Nicotine & tobacco research2013PMID 22955246

  • Treatment discontinuation with methylphenidate in adults with attention deficit hyperactivity disorder: a meta-analysis of randomized clinical trials.

    European journal of clinical pharmacology2013PMID 22983311

  • Psychological and physiological effects of bupropion compared to methylphenidate after prolonged administration in healthy volunteers (NCT00285155).

    European journal of clinical pharmacology2013PMID 23052417Indexed under methylphenidate in PubMed's chemical list

  • Genetic evidence for the association of the hypothalamic-pituitary-adrenal (HPA) axis with ADHD and methylphenidate treatment response.

    Neuromolecular medicine2013PMID 23055001

  • Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD.

    Journal of psychiatric research2013PMID 23088865

  • Dopaminergic dysfunction in abstinent dexamphetamine users: results from a pharmacological fMRI study using a reward anticipation task and a methylphenidate challenge.

    Drug and alcohol dependence2013PMID 23142493

  • Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials.

    Reviews on recent clinical trials2013PMID 23157376Indexed under methylphenidate in PubMed's chemical list

  • MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit/hyperactivity disorder.

    European neuropsychopharmacology2013PMID 23165220

  • Methylphenidate and amantadine to stimulate reawakening in comatose patients resuscitated from cardiac arrest.

    Resuscitation2013PMID 23178867

  • Parents' attitudes toward methylphenidate using n-of-1 trial: a pilot study.

    Attention deficit and hyperactivity disorders2013PMID 23242806

  • A randomized, controlled, pilot trial of methylphenidate and cognitive-behavioral group therapy for cocaine dependence in heroin prescription.

    Journal of clinical psychopharmacology2013PMID 23277248

  • NWP06, an extended-release oral suspension of methylphenidate, improved attention-deficit/hyperactivity disorder symptoms compared with placebo in a laboratory classroom study.

    Journal of child and adolescent psychopharmacology2013PMID 23289899

  • Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents.

    Journal of child psychology and psychiatry, and allied disciplines2013PMID 23294014

  • Comorbidities in ADHD children treated with methylphenidate: a database study.

    BMC psychiatry2013PMID 23294623

  • Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.

    Addiction (Abingdon, England)2013PMID 23297867

  • Risk of methylphenidate-induced prehypertension in normotensive adult smokers with attention deficit hyperactivity disorder.

    Journal of clinical hypertension (Greenwich, Conn.)2013PMID 23339731

  • Methylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorder.

    Neuropsychopharmacology2013PMID 23340519

  • Two different solicitation methods for obtaining information on adverse events associated with methylphenidate in adolescents: a 12-week multicenter, open-label study.

    Journal of child and adolescent psychopharmacology2013PMID 23347125

  • Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial.

    BMC psychiatry2013PMID 23347693

  • Effects of methylphenidate on resting-state brain activity in normal adults: an fMRI study.

    Neuroscience bulletin2013PMID 23361519

  • Monoaminergic dysfunction in recreational users of dexamphetamine.

    European neuropsychopharmacology2013PMID 23415394

  • Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.

    BMC psychiatry2013PMID 23446109

  • Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.

    Journal of autism and developmental disorders2013PMID 23468071

  • Long-acting versus short-acting methylphenidate for paediatric ADHD: a systematic review and meta-analysis of comparative efficacy.

    BMJ open2013PMID 23503579Returned by a PubMed search for methylphenidate

  • Pharmacokinetics of coadministration of guanfacine extended release and methylphenidate extended release.

    Drugs in R&D2013PMID 23519656

  • Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.

    European journal of paediatric neurology2013PMID 23541676

  • Interventions for preschool children at high risk for ADHD: a comparative effectiveness review.

    Pediatrics2013PMID 23545375

  • Designing a trial to evaluate potential treatments for apathy in dementia: the apathy in dementia methylphenidate trial (ADMET).

    The American journal of geriatric psychiatry2013PMID 23567407

  • Effect of single dose methylphenidate on walking and postural stability under single- and dual-task conditions in older adults--a double-blind randomized control trial.

    The journals of gerontology2013PMID 23580740

  • Methylphenidate reduces functional connectivity of nucleus accumbens in brain reward circuit.

    Psychopharmacology2013PMID 23604336

  • Norepinephrine genes predict response time variability and methylphenidate-induced changes in neuropsychological function in attention deficit hyperactivity disorder.

    Journal of clinical psychopharmacology2013PMID 23609393

The next 50 papers

← Previous 50